Cogent Biosciences Inc (COGT)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Andrew R. Robbins |
| Employees: | 80 |
| Web site: | cogentbio.com |
|
275 WYMAN STREET, 3RD FLOOR, WALTHAM, MA, 02451
617-945-5576
| |
Are you looking for this stock instead?
| Date | Ratio |
|---|---|
| 2020-11-09 | 1:4 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Cogent Biosciences, Inc. focuses on developing precision therapies for genetically defined diseases. Lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis.
Please log in first to see chart